#NeuroImmunology
LightNews LightNews
medidier.bsky.social
One thing that I usually don't fully grasp is how all the specific autoimmune mito/cellular findings connect clearly with brainstem dysfunction/damage. Bc if I am 99% convinced of one thing about my illness is that brainstem/ANS (neuroimmunology) plays an absolute key role.
February 4, 2026 at 11:59 AM
glennmaltais.bsky.social
Neuroimmunology: Can you think yourself healthy? www.nature.com/articles/d41...
Neuroimmunology: Can you think yourself healthy?
Link between brain and immune system could lead to innovative new treatments.
www.nature.com
February 3, 2026 at 11:49 PM
snarasimhan.bsky.social
Cell is hiring!

Do you have a background in #neuroscience or #immunology? Better still, #neuroimmunology? Cell has an opening for a full-time scientific editor. Role will be based out of any one of our offices in Medford, MA, UK, Spain, Netherlands, China tinyurl.com/4ma236xn @cp-cell.bsky.social
Scientific Editor, Cell
Cell has an opening for a full-time scientific editor. If you are a passionate, mission-driven team player who loves thinking broadly about science and wants to have a positive impact, we invite you t...
nam11.safelinks.protection.outlook.com
February 3, 2026 at 8:27 PM
yspi.bsky.social
#ySPI #WinterWebinar #Immunology #Neuroimmunology #Neuroscience #DevelopmentalImmunology #NeonatalImmunity #BrainInfection #PhDLife #PostdocLife #WomenInSTEM #WomenInScience #EarlyCareerResearchers
@yefis-immunology.bsky.social @efis-immunology.bsky.social @iuis-online.bsky.social
February 3, 2026 at 10:22 AM
sallybourliakas.bsky.social
🧪 #LongCovid #MECFS

x.com/dysclinic/st...
Neuroimmunology ME/CFS Long COVID POTS Autoimmunity Postive ANA, assephospholipid and other antibodies High prevalence of comorbie autoimmune disorders Elevated adrenergic and IgG t0 thyroglobulin and IF NO Postive response to Immunotherapies in a subset of Immune dysregulation Teel exhauston Chronic activation of subset of COS•T cels Increased naive B-cell numbers Increased prontammator cytokines Mast cel hyperactivity Sympathetic overactivty Impaired infammatory refer via Neuroinflammation Microglial activation Elevated peoinflammatory cytokines Altered blood-brain barrier Central autonomie networks aterations Abnomal 7T MRI Indings Brain glucose metabolism alteration Cerebral hypoperfusion Reduced cardiac stroke volume Glymphatie system alterations Venous congestion Endothelial dysfunction. Hypecoagulable state Possible microciots Systemic hypovolemia Autonomic dysregulation Connective tissue abnormalites improved cerebral pertusion with supine vs. standing position Mitochondrial dysfunction Chronie taique and posti Respration, bionnergeties and mitochondria-related gene expression changes Oxidative stress and mitochondrial damage biomarkers with elevated lactate, peroxide and superoxide Impared ATP production Abnormal 2-day CPET Reduced systemie oxygen 06:35 94 Hot off the press: my new paper that moves this field forward & • and changes the narrative on what #POTS, #MECFS and #LongCOVID are... Neuroimmune Disorders! The brain and the autonomic nervous system are involved in the immune system regulation. There is evidence of autoimmunity, immune dysregulation, cerebral hypoperfusion, neuroinflammation and other mechanisms in all three disorders. #Neuroimmunology is a field that should embrace these disorders: #MultipleSclerosis, the staple of neuroimmunology, used to be called hysterical paralysis before CT and MRI were invented. We're at the same crossroads with these disorders. X These disorders are not "mysterious", "anxiety", "deconditioning," "functional neurologic" etc. etc. !! Classifying these disorders as neuroimmune and including them as part of neuroimmunology training is critical. • #PatientCare and lives of millions of people living with these disabling conditions are at stake! Post your reply
February 3, 2026 at 6:43 AM
idibaps.bsky.social
🆕It begins the selection process for doctoral students in neuroimmunology and neurodegeneration for the #IGNITION project

✔️13 36-month predoctoral contracts (2 at #IDIBAPS)
✔️Fully funded by #MSCA
✔️Deadline 01/04

👉https://f.mtr.cool/swezcdpdra
February 2, 2026 at 10:02 AM
neurowithmelike.bsky.social
Additionally, during my degree I had the opportunity to study in Spain through the Erasmus program. It was there, Barcelona&Madrid, that I first encountered neuroimmunology, which shifted my initial interest from anatomy. I continue to hold a deep appreciation and gratitude for Spanish scientists.💜
January 31, 2026 at 10:34 AM
imtadvances.bsky.social
📢 Call for papers!

Immunotherapy Advances invites submissions for our Special Collection on Neuroimmunology and Immunotherapy, guest edited by Marianne Boes & Majid Ghareghanim.

Deadline: March 2026.

Submit now: https://bit.ly/45mr1m8
January 31, 2026 at 10:27 AM
abfbrain.bsky.social
Leadership Spotlight: Please welcome our new board member, Dr. Richard M. Ransohoff.
Leadership Spotlight: New Board Member. Richard M. Ransohoff, MD is a Venture Partner at Third Rock Ventures, where he helps build new companies focused on serious unmet needs in neurology, immunology, and neuropsychiatry. He is a scientific co-founder of Abata Therapeutics and helped launch Trace Neuroscience. A former Cleveland Clinic neurologist and founder of the Neuroinflammation Research Center, he is a global leader in neuroimmunology with more than 460 published scientific articles and numerous honors for his impact on research and patient care.
January 30, 2026 at 9:02 PM
soyonhonglab.bsky.social
🙏🙏 to entire team esp co-lead Tim Bartels. So proud of @seppedeschepper.bsky.social brilliant first postdoc who now leads his own at VIB. 🙏🙏🙏to @chanzuckerberg.bsky.social for supporting the project from early pilot phase. Contact us if u want to explore next steps in PD gut/brain neuroimmunology!
ukdri.ac.uk UK Dementia Research Institute @ukdri.ac.uk · 8d
Could targeting the gut's immune system tackle the early stages of Parkinson's? 🧠

A new study from @soyonhonglab.bsky.social & Tim Bartels (UK DRI at UCL) has revealed how Parkinson’s spreads from the gut to the brain - with the help of immune cells.

Read more 👉 www.ukdri.ac.uk/news-and-eve...
Targeting the gut's immune system could tackle early stages of Parkinson's
New research, led by Dr Soyon Hong and Dr Tim Bartels at the UK DRI at UCL, has revealed how Parkinson’s spreads from the gut to the brain, with the hel
www.ukdri.ac.uk
January 28, 2026 at 5:21 PM
cmn-vib.bsky.social
This work builds on Seppe’s postdoc research at @ucl.ac.uk / @ukdri.ac.uk , and we’re excited for the next discoveries from his own lab at VIB-UAntwerp Center for Molecular Neurology (CMN), focusing on neuroimmunology in neurodegeneration. @viblifesciences.bsky.social @uantwerpen.be
January 28, 2026 at 4:46 PM
dementiasplatform.bsky.social
On World Lewy Body Dementia Day, we are highlighting 2 neuroimmunology studies from our team at the University of Cambridge: IMPRINT is looking at the onset of the disease; and IMPACT, investigating the role of brain inflammation in DLB with PET scanning. zurl.co/EhBs5
January 28, 2026 at 11:34 AM
tenuretracker.bsky.social
National Institutes of Health (NIH) is hiring:
Postdoctoral Fellow in Translational Neuroimmunology
January 28, 2026 at 7:30 AM
tomkindlon.bsky.social
New:
26-minute radio interview on ABC (Australian national radio)

www.abc.net.au/listen/progr...

Haven't listened so far. Not familiar with Dr Smith but Professor Marshall-Gradisnik of NCNED should be good

#MEcfs #CFS #PwME #MyalgicEncephalomyelitis #ChronicFatigueSyndrome
Image Details Understanding invisible illness like Chronic Fatigue Syndrome.(Supplied: Alex Green Pexels) Program:Chronic Fatigue Syndrome new research Program:Nightlife 2h ago2 hours ago Space to play or pause, M to mute, left and right arrows to seek, up and down arrows for volume. Play Duration: 26 minutes 6 seconds26m It has long been one of the most complicated and complex medical conditions and routinely dismissed by friends, family and even medical professionals because - maybe it's in your head? Myalgic Encephalomyelitis or Chronic Fatigue Syndrome has never had a one-stop reliable diagnostic test, the cause can be unknown and the symptoms are broad. The only sure thing is how debilitating it is to have ME/CFS. But my next guests have dedicated years of their professional careers to ME/CFS .. one in the lab, the other in the doctor's surgery. The Director of Griffith University's National Centre for Neuroimmunology and Emerging Diseases (NCNED) and senior author of a new Australian study that could be a turning point for understanding and treatment of ME/CFS .. Professor Sonya Marshall-Gradisnik and Dr Peter Smith - a clinician who treats ME/CFS patients and allergy specialist with a PhD in molecular biology joined Bern Young on Nightlife.
January 25, 2026 at 1:54 PM
abfbrain.bsky.social
Researchers at the National Centre for Neuroimmunology and Emerging Diseases (NCNED), @griffith.edu.au, studied MRI data indicating that COVID-19 infection can cause long-lasting changes to the microstructure and chemical makeup of the brain, reducing the intensity of myelin signals. #LongCOVID
Research Discovery: COVID-19 likely affects neurological health for everyone, even those who fully recover. Neurological Effects: Changes in brain tissue structure and neurochemical levels. Key Findings: While previous studies have looked at the lasting symptoms of “long COVID,” MRI scans now reveal that the infection can alter brain structure and chemical makeup, even among those who fully recover. These changes affect the signal intensity of myelin, the protective coating of nerve fibers. What's Next? Long-term follow-up studies are needed to determine if these effects change over time or affect the brain permanently.
January 24, 2026 at 6:00 PM
neurowithmelike.bsky.social
Hi and thank you Dr. Davis.I live in Turkey, but I have no geographical restrictions for relocation. I want to work specifically in neuroscience, neuroimmunology. My areas of interest are anatomy, exercise physiology and neuroscience in my general experience. :)
January 23, 2026 at 1:41 PM
esdrorg.bsky.social
We are happy to announce the next live and free Kitchen episode on "Adult and pediatric atopic dermatitis through the lenses of neuroimmunology" with Nicolas Gaudenzio

Join us next month, on Wednesday 11 February at 13:30 CET!
Chairs: Georg Stary &Katia Boniface

Free registration: lnkd.in/eTNaJajg
January 20, 2026 at 9:05 AM
hlemmik.bsky.social
We thought this immune receptor contributed to brain development and function because several groups had reported that knockout mice show anxiety-like behaviour and cognitive impairments. #behaviour #knockoutmice #neuroimmunology
January 19, 2026 at 5:42 PM
maskblochtx.bsky.social
Pretty alarming stuff from this study by Griffith University’s National Centre for Neuroimmunology & Emerging Disease (NCNED).
#covi̇d19 #longcovid #braindamage #coronavirus #publichealth #wekeepussafe
On a light blue background is a graphic breaking down a research study into three sections: study overview, key findings, and implications and next steps. Each section has a colored bubble that is enlarged to indicate that sections topic. The top of the graphic reads: “Who: Researchers at Griffith University’s National Centre for Neuroimmunology & Emerging Disease (NCNED).” Under the title of the graphic is an enlarged, blue bubble with the mask bloc htx logo inside the bubble with blue text reading: “mask bloc htx” with a blue KN95 mask. Under the section bubble is black text for the topic of this slide “Study Overview,” and under the topic text, in black text is the study’s results findings reading: “What: Multimodal MRI investigation of brain health in three groups: • Individuals with Long COVID • People who consider themselves fully recovered from COVID‑19 • Uninfected controls Goal: Detect subtle structural and neuro‑chemical changes that persist after infection (published: Brain, Behavior, & Immunity – Health (Nov 2025)).” The text reading: “changes that persist after infection “ is in red text. There is a smaller light green bubble to the right of the enlarged blue bubble that indicates a section for “key findings’ in black text and an orange bubble to the right of the light green bubble that indicates the section “implications and next steps” in black text as well. On a light blue background is a graphic breaking down a research study into three sections, study overview, key findings, and implications and next steps. Each section has a bubble that is enlarged to indicate that sections topic. The top of the graphic reads: “Who: Researchers at Griffith University’s National Centre for Neuroimmunology & Emerging Disease (NCNED).” Under the title of the graphic is black text reading “Key Findings” that indicates the topic for this slide. Under “Key findings” is black text is the results for this study’s findings reading: “What: Gray‑matter & white‑matter alterations: • Significant differences in tissue microstructure across all brain regions examined (memory, cognition, overall brain health) • Neuro‑chemical shifts • MRI spectroscopy revealed altered concentrations of metabolites linked to neuronal integrity and inflammation • Present in “recovered” participants • Even participants who reported no lingering symptoms showed measurable changes, not just those with Long COVID.” The text reading: “Significant differences in tissue microstructure across all brain regions examined (memory, cognition, overall brain health)” is in red text, as well as text reading: “Even participants who reported no lingering symptoms showed measurable changes, not just those with Long COVID.” Under the text describing the topic of this slide is smaller blue section bubble with black text underneath that reads: “Study Overview.” Next to this section bubble is an enlarged light green section bubble with the mask bloc htx logo inside the bubble with blue text reading: “mask bloc htx” with a blue KN95 mask. Next to the enlarged light green section bubble is a smaller orange section bubble with black text underneath reading: “Implications and Next Steps.” On a light blue background is a graphic breaking down a research study into three sections, study overview, key findings, and implications and next steps. Each section has a bubble that is enlarged to indicate that sections topic. The top of the graphic reads: “Who: Researchers at Griffith University’s National Centre for Neuroimmunology & Emerging Disease (NCNED).” Under the title of the graphic, on the left of the graphis is an enlarged blue section bubble with black text underneath reading: “Study Overview.” Next to the enlarged blue section bubble is black text reading: “Key Findings.” Under “Key Findings” is smaller light green section bubble and next to “Key Findings” is an enlarged orange section bubble with the mask bloc htx logo inside the bubble with blue text reading: “mask bloc htx” with a blue KN95 mask. Under the enlarged orange section bubble is text for the topic of this slide “Implications and Next Steps.” Under this text is the results of the study’s findings in black text reading: “What: • Clinical relevance – may explain persistent cognitive complaints (memory lapses, reduced concentration, fatigue) observed months‑to‑years post‑infection • Public‑health recommendation – need neurological follow‑up for ALL COVID‑19 survivors • Future research – Longitudinal MRI studies tracking if these changes resolve, stabilize, or progress; explore therapeutic interventions (rehabilitation, anti‑inflammatory strategies). • Practitioners – consider neuro‑imaging or cognitive screening when EVERY patient reports subtle brain‑related symptoms The text reading: “ observed months‑to‑years post‑infection” and “for ALL COVID‑19 survivors” and “when EVERY patient reports subtle brain‑related symptoms” is in red text.
January 18, 2026 at 9:42 PM
jonasneher.bsky.social
🧠🦠 New preprint out!

Systemic inflammation fundamentally reshapes amyloid plaques — shifting them toward non-compacted, filamentous Aβ states that strongly predict neuritic damage across mouse models and human Alzheimer’s disease.

#Alzheimers #Neuroimmunology #Microglia #Amyloid #PET #Inflammation
Non-compacted, PET-insensitive amyloid states increase after systemic inflammation and predict neuritic damage across Aβ pathology models and Alzheimer patients
Neuroinflammation is a key modulator of Alzheimer’s disease (AD) risk, yet the impact of non-genetic inflammatory risk factors – such as systemic inflammation – remains poorly defined. Building on our...
www.researchsquare.com
January 17, 2026 at 6:30 AM
wheelieoutthere.bsky.social
Deadline for the Summer 2026 Clinical Mentorship Programs Next Week

Are you or do you know a current Medical Student or Psychology Graduate Student who might be interested in the field of neuroimmunology & #MultipleSclerosis?

Please share this hands-on experience w your networks! lnkd.in/eKWRyaDY
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
January 16, 2026 at 3:01 PM
medchemexpress.bsky.social
📰New & Featured | 🧠Cell: How could #EBV help trigger #MS?

A new Cell study shows that EBV-infected B cells can:
🧬Capture myelin antigens in the #CNS
🚫Bypass immune tolerance
⚡Trigger early demyelinating lesions

#MultipleSclerosis #Neuroimmunology #EpsteinBarrVirus
January 16, 2026 at 3:01 PM
ralfwittenbrink.bsky.social
Genesung von COVID-19 keine Symptome mehr aufweisen, können dennoch Langzeitfolgen des Virus auf das Gehirn haben“, so Studienautor Kiran Thapaliya, wissenschaftlicher Mitarbeiter am National Centre for Neuroimmunology and Emerging Diseases.

www.psypost.org/covid-19-inf...
COVID-19 infection may alter brain microstructure even in people who fully recover
Researchers have found that individuals with no lingering COVID-19 symptoms still exhibit distinct changes in brain tissue integrity and neurochemistry compared to those who were never infected.
www.psypost.org
January 15, 2026 at 11:00 PM
rarediseaseadvisor.bsky.social
In patients with #NMOSD, specific therapies approved by the @fda.gov demonstrate superior efficacy and safety compared with #Rituximab and off-label treatments. Study in Neurology Neuroimmunology & Neuroinflammation.

Read more: https://bit.ly/4pCwEqb

#RareDisease #Neurology
FDA-Approved Therapies for NMOSD Superior to Rituximab and Off-Label Treatments
FDA-approved NMOSD therapies such as inebilizumab and C5 inhibitors show better efficacy than rituximab or off-label treatments.
bit.ly
January 15, 2026 at 10:11 PM
openboxscience.bsky.social
IT'S TODAY (1/15)!
OBS Neuroimmunology Webinar — Monthly on the Third Thursday at 12 PM ET

#1 Lymphoid gene expression supports neuroprotective microglia function (Nature 2025)
BY: Jessica Crowley and Matthew Challman (Icahn School of Medicine at Mount Sinai)

*Zoom: us02web.zoom.us/meeting/regi...
January 15, 2026 at 2:03 PM